Orchid Pharma Limited
Orchid Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ORCHPHARMA and BSE: 524372 (ISIN INE191A01027).
It has a market capitalisation of ₹5,351 crore, a last close of ₹893.50 on 2026-10-19, a one-year return of 23.3%.
Valuation: a price-to-earnings ratio of 499x, a price-to-book ratio of 3.42x, a dividend yield of 0.0%.
Profitability: return on equity of 0.0%, return on capital employed of 1.2%, an operating margin of 4.1%.
Growth: sales growth of 22.8% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.19x, promoter holding of 74.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 5,351 |
| Last close | ₹893.50 |
| P/E (TTM) | 499x |
| P/B | 3.42x |
| Dividend yield | 0.0% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 1.2% |
| Operating margin (TTM) | 4.1% |
| Sales growth, 3-year CAGR | 22.8% |
| Debt / equity | 0.19x |
| Promoter holding | 74.5% |
| 1-year return | 23.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means